Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Addiction. 2017 Mar 3;112(7):1302–1314. doi: 10.1111/add.13783

Figure 3. Impact of different prevention and treatment scenarios on chronic HCV prevalence over time in Scotland amongst community PWID, incarcerated PWID and all PWID.

Figure 3

Lines represent the median chronic HCV prevalence, with the shaded area representing the 95% CrI for the status quo projection (no scale-up) from 2015 onwards. HCV prevalence data points shown for comparison with 95% confidence intervals.